RLX Technology Gains 2.2% on European Expansion and Nicotine Pouch Bet
0h ago|5 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
rlx-technologychina-stocks
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
RLX Technology Inc. shares advanced 2.23% to trade at $1.83 as of 03:54 UTC today, following reports the Chinese vaping products manufacturer is expanding into European markets and diversifying into nicotine pouch products. The stock traded within a narrow range of $1.79 to $1.84 during the session, reflecting measured investor optimism toward the strategic pivot. This move represents a significant shift for the company, which derives the majority of its revenue from China's heavily regulated e-cigarette market.
RLX Technology, once a dominant player in China's vaping industry, has faced severe regulatory pressure since 2021 when Chinese authorities began implementing strict regulations on e-cigarette products. The State Tobacco Monopoly Administration effectively nationalized distribution channels and imposed stringent marketing restrictions, dramatically compressing industry margins. The company's revenue peaked at approximately $1.3 billion in 2021 before declining sharply to $183 million in 2023 according to public filings.
The current macro environment presents both challenges and opportunities for this expansion. European markets generally maintain more predictable regulatory frameworks for reduced-risk nicotine products compared to China's evolving restrictions. However, the European Union is simultaneously considering tighter regulations on nicotine pouches and similar products, creating potential headwinds. The timing coincides with increased scrutiny of Chinese listings on US exchanges, adding another layer of complexity to RLX's strategic repositioning.
The catalyst for this expansion appears driven by necessity rather than optional growth. With China's e-cigarette market effectively constrained by state control, international diversification represents one of the few viable paths for revenue growth. The nicotine pouch market meanwhile has shown strong growth globally, projected to reach $15 billion by 2028 according to industry estimates, providing a logical adjacent market for expansion.
RLX Technology's stock performance reflects the challenging environment the company navigates. At $1.83, the share price remains approximately 95% below its February 2021 peak of $35.00, shortly after its NYSE listing. The company's market capitalization of approximately $2.8 billion contrasts sharply with its peak valuation exceeding $54 billion during the retail trading frenzy of early 2021.
The day's trading volume of approximately 2.1 million shares exceeded its 30-day average of 1.8 million shares, indicating heightened investor interest following the expansion news. This represents a 16% increase in volume activity compared to typical trading patterns. The stock's performance notably outperformed the broader Hang Seng Index, which declined 0.8% during the same trading session.
RLX's financial metrics reveal the compression caused by regulatory changes. The company's gross margin contracted from 43.2% in 2022 to 38.1% in 2023, reflecting increased compliance costs and pricing pressure. Research and development expenditure increased to 8.7% of revenue in 2023 from 5.2% in 2022, indicating investment in new product categories like nicotine pouches.
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $183M | $854M | -78.6% |
| Gross Margin | 38.1% | 43.2% | -510 bps |
| R&D Expense | $16M | $44M | -63.6% |
The European expansion directly benefits RLX Technology by providing access to larger, more stable markets with higher disposable income. The strategy potentially positions RLX against established tobacco alternatives companies like Swedish Match (SWMAF) and British American Tobacco (BTI), though at a significantly smaller scale initially. European nicotine pouch markets have grown at approximately 15% annually since 2022, offering substantial growth potential compared to China's constrained environment.
Second-order effects may include increased competitive pressure on European nicotine product manufacturers, particularly smaller regional players who may lack RLX's manufacturing scale and technological expertise in vapor products. The expansion could also create opportunities for European distributors and retail chains seeking partnerships with an established Asian manufacturer entering the market.
A significant counterargument questions whether RLX can successfully manage European regulatory environments and consumer preferences fundamentally different from China's market. The company faces established competitors with decades of market experience and brand loyalty. European consumers may also perceive Chinese nicotine products differently than domestic brands, potentially limiting premium pricing opportunities.
Trading flow data indicates institutional investors remain cautious, with short interest maintaining approximately 8% of float. Options activity shows increased put volume at the $1.50 strike price, suggesting some traders anticipate potential downward pressure despite the positive news. The stock's low volatility suggests most large positions remain unchanged pending concrete financial results from the new strategy.
Investors should monitor RLX Technology's Q3 2026 earnings release, expected in mid-November, for initial financial metrics from the European expansion. Management commentary on customer acquisition costs and initial market penetration rates will provide crucial early indicators of strategy success. The company's market share in key European countries like Germany and the United Kingdom will be particularly informative relative to established competitors.
Regulatory developments in both Europe and China present significant watch points. The European Commission's ongoing review of nicotine pouch regulations, expected to conclude by Q1 2027, could dramatically alter the market landscape. Simultaneously, any further regulatory changes in China regarding export permissions or manufacturing standards could affect RLX's cost structure and operational flexibility.
Technical levels provide clear benchmarks for the stock's trajectory. Resistance sits at the $2.00 psychological level, which has contained rallies since April 2026. Support remains at the 50-day moving average of $1.72, a level that has provided stability during recent trading sessions. A sustained break above $2.10 would signal potentially stronger momentum behind the expansion story.
Nicotine pouches are small, white packets containing nicotine, flavorings, and other ingredients that users place between their gum and lip. Unlike traditional tobacco products, they contain no tobacco leaf, instead using synthesized nicotine. They differ from vaping products because they involve no inhalation, no vapor production, and are used discreetly without drawing attention. The product category has grown rapidly in Europe and North America as smoke-free alternatives.
The European expansion represents a fundamental strategic shift rather than incremental growth. RLX derived over 95% of its 2023 revenue from China, making international markets essentially new territory. The company's manufacturing infrastructure and supply chain remain primarily China-based, meaning products for European markets will initially face export logistics challenges and potentially higher costs compared to local manufacturers.
European regulation presents different challenges than China's centralized control. The European Union regulates nicotine products under the Tobacco Products Directive, which requires extensive pre-market notification, ingredient disclosure, and packaging restrictions. Individual countries like Sweden and Germany maintain additional national regulations. The EU is currently considering classifying nicotine pouches as tobacco products, which would impose stricter marketing rules and higher taxes.
RLX Technology's diversification strategy addresses existential threats from Chinese regulation through necessary international expansion.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
AiX is our free MetaTrader 4 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.